<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18019/1028-4427-2019-25-1-6-14</article-id><article-id custom-type="elpub" pub-id-type="custom">genort-2424</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>Комментарии к рекомендациям EULAR/EFORT по лечению пациентов старше 50 лет с низкоэнергетическими переломами и профилактике у них повторных переломов</article-title><trans-title-group xml:lang="en"><trans-title>Comments to EULAR/EFORT recommendations for management of patients older than 50 yearswith a fragility fracture and prevention of subsequent fractures</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кочиш</surname><given-names>А.Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kochish</surname><given-names>A.Yu.</given-names></name></name-alternatives><email xlink:type="simple">auk1959@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лесняк</surname><given-names>О.М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lesnyak</surname><given-names>О.M.</given-names></name></name-alternatives><email xlink:type="simple">olga.m.lesnyak@yandex.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беленький</surname><given-names>И.Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Belenkiy</surname><given-names>I.G.</given-names></name></name-alternatives><email xlink:type="simple">belenkiy.trauma@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белова</surname><given-names>К.Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Belova</surname><given-names>К.Yu.</given-names></name></name-alternatives><email xlink:type="simple">ksbelova@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евстигнеева</surname><given-names>Л.П.</given-names></name><name name-style="western" xml:lang="en"><surname>Evstigneeva</surname><given-names>L.P.</given-names></name></name-alternatives><email xlink:type="simple">levstigneyeva@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ершова</surname><given-names>О.Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Ershova</surname><given-names>О.B.</given-names></name></name-alternatives><email xlink:type="simple">yarosteoporosis@list.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богопольская</surname><given-names>А.С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogopolskaya1</surname><given-names>A.S.</given-names></name></name-alternatives><email xlink:type="simple">auk1959@mail.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>03</month><year>2019</year></pub-date><volume>25</volume><issue>1</issue><issue-title>№ 1 (2019)</issue-title><fpage>6</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кочиш А., Лесняк О., Беленький И., Белова К., Евстигнеева Л., Ершова О., Богопольская А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Кочиш А., Лесняк О., Беленький И., Белова К., Евстигнеева Л., Ершова О., Богопольская А.</copyright-holder><copyright-holder xml:lang="en">Kochish A., Lesnyak О., Belenkiy I., Belova К., Evstigneeva L., Ershova О., Bogopolskaya1 A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/2424">https://www.ilizarov-journal.com/jour/article/view/2424</self-uri><abstract><p>Остеопороз – серьёзная медицинская и социальная проблема, которой в настоящее время уделяется большое внимание. В декабре 2016 года опубликованы разработанные Европейской антиревматической лигой (European League Against Rheumatism – EULAR) и Европейской Федерацией национальных ассоциаций ортопедов и травматологов (European Federation of National Associations of Orthopaedics and Traumatology – EFORT) рекомендации по лечению пациентов с переломами на фоне остеопороза. Авторы прокомментировали их с учетом возможностей и особенностей условий здравоохранения Российской Федерации. Указано на необходимость оптимизации системы организации медицинской помощи с целью обеспечения своевременного поступления пациентов с остеопорозными переломами костей в травматологические стационары и обеспечения выполнения 48-часового протокола при операциях по поводу переломов проксимального отдела бедренной кости. Описаны особенности техники остеосинтеза и рекомендованных для использования в остеопорозной кости имплантатов. Отмечена серьёзная роль создания системы профилактики повторных переломов с оценкой их риска. Указано на высокую эффективность реабилитационного лечения, основанного на понимании пациентом патогенеза патологического процесса. Конкретизированы специфические особенности немедикаментозного и медикаментозного лечения остеопороза у пациентов с низкоэнергетическими переломами. </p></abstract><trans-abstract xml:lang="en"><p>Osteoporosis is considered a serious public health and social concern that catches public attention worldwide. A set of recommendations for management of patients with fragility fractures were developed on an initiative of the European League Against Rheumatism (EULAR) and the European Federation of National Associations of Orthopedics and Traumatology (EFORT) in December 2016. Authors have reviewed the recommendations through provision of health care practices in the Russian Federation. A protocol of hip fracture surgery within 48 hours of admission to trauma services for fragility cases represent a needful tool for optimization of medical care system. Specific techniques and implant designs for fracture fixation in osteoporotic bone are described with the focus on subsequent fractures prevention and fracture risk assessment. Effective rehabilitation is shown to rely on patient's understanding of the pathogenesis of the pathological process. Specific drug therapies and non-pharmacological treatment can be administered for osteoporotic patients with low-energy fractures.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
